Success Story: NAILG Helped a Chinese Expert Earn NIW Approval via Premium Processing
Client’s Testimonial:
“WeGreened’s streamlined process and responsive team made my NIW application smooth and stress-free. Their clear guidance saved me time and helped me present my achievements effectively. Highly recommended.”
On March 31st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Expert in the Field of Medical Research (Approval Notice).
General Field: Medical Research
Position at the Time of Case Filing: Unemployed
Country of Origin: China
Approval Notice Date: March 31st, 2025
Processing Time: 1 month, 27 days (Premium Processing Requested)
Case Summary:
The North America Immigration Law Group (NAILG) is delighted to announce the successful approval of an I-140 petition under the EB-2 category with a National Interest Waiver (NIW) for a highly skilled expert in medical research. The petition was filed with premium processing and was approved within two months, recognizing the client’s groundbreaking contributions to the development of personalized treatment strategies for cancer and other complex diseases.
Our client, who holds an M.D., is a specialist in medical research with a focus on utilizing statistical models and artificial intelligence to interpret genomic and clinical datasets. Her work supports the development of customized therapies that aim to maximize treatment efficacy and minimize adverse effects in patients suffering from serious illnesses, particularly cancer. She is currently employed in a research-oriented position within the biotechnology sector, where she continues to pursue this nationally important work.
To establish that the client is well-positioned to advance her proposed endeavor and that her work holds substantial merit and national importance, our firm presented a thorough body of evidence, highlighting:
- Robust Publication Record: The client has authored 13 peer-reviewed journal articles, including 7 as first author, and 1 first-authored abstract, underscoring her leadership in publishing impactful research in high-impact journals.
- Meaningful Research Impact: Her published work has been cited 126 times, with several papers ranking among the top 10–20% of most cited in the field of Clinical Medicine for their publication year. This strong citation record reflects significant scholarly influence and validation from the broader scientific community.
- Peer Recognition and Implementation: The client’s research has been directly cited by other specialists working in cancer, demonstrating her role in shaping clinical practice and advocating individualized treatment
- Expert Peer Reviewer: Her professional standing is further illustrated by her peer review activity for recognized scientific journals, reinforcing her authority in the field and the trusted judgment of other researchers’ work.
- Original Contributions of Major Significance: The petition emphasized her innovative work on the clinical use of statistical algorithms and evidence-based treatment that contribute directly to enhanced patient survival and recovery strategies.
This approval underscores NAILG’s commitment to supporting top-tier researchers in emerging biomedical fields whose work is shaping the future of medicine and contributing to the well-being of society.